Literature DB >> 34672923

Strengthening Pandemic Preparedness Through Noncommunicable Disease Strategies.

Deliana A Kostova1, Ronald L Moolenaar2, Gretchen Van Vliet3, Ally Lasu3, Michael Mahar2, Patricia Richter2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34672923      PMCID: PMC8588872          DOI: 10.5888/pcd18.210237

Source DB:  PubMed          Journal:  Prev Chronic Dis        ISSN: 1545-1151            Impact factor:   2.830


× No keyword cloud information.
The COVID-19 pandemic has demonstrated the effect of noncommunicable diseases (NCDs) on infectious disease outcomes. This effect can be observed at both the individual and the population level. At the individual level, the presence of preexisting chronic conditions increases a patient’s risk of severe COVID-19 disease (1). At the population level, the aggregate prevalence of chronic conditions could compound the pandemic’s overall burden on health systems and the economy (2). Given the role of NCDs in infectious disease and pandemic outcomes, future pandemic preparedness plans could be improved by incorporating selected NCD-related objectives to complement the plans’ core focus on infectious diseases. In a previous publication, we presented a conceptual framework that outlined the points of convergence among infectious disease outbreaks, pandemic preparedness, and NCDs (3). We ascertained that NCDs play a role in 4 factors that determine the course of infectious disease outbreaks: the host population, the disease agent, the physical environment, and the social environment. First, the increased prevalence of NCDs in a host population raises its susceptibility to outbreaks, while also playing into a reverse feedback loop where infection in an individual patient can independently generate NCD sequelae, requiring treatment of both. Second, the presence of NCDs and their risk factors can exacerbate the pathogenicity of the infectious disease agent. Third, the prevalence of NCDs shapes the physical environment by steering health systems toward primary care, where the resulting infrastructure can support pandemic response by increasing staffing and supplementing supply chains. Fourth, the prevalence of NCDs affects the social environment by driving health care budgets and providing avenues for sustainable financing. In summary, the multipronged role of NCDs in infectious disease outbreaks merits their consideration in pandemic strategy building. The International Health Regulations (IHR) (4) constitute a global agreement among 196 signatory countries that represents the world’s coordinated effort to prepare for and limit the spread of epidemics. Established in 2005 under the auspices of the World Health Organization, IHR delineates a set of approaches that participating countries can use to strengthen key pandemic capacities, including capacities for surveillance, risk communications, human resources, laboratory testing, national legislation, coordination, response, and operational readiness (5). In 2014, multiple countries partnered to accelerate compliance with the 2005 IHR by developing the Global Health Security Agenda (GSHA) (6). However, despite the demonstrable relevance of NCDs to pandemic outcomes, neither IHR nor GHSA preparedness plans refer to NCD-related aspects of public health protection, potentially overlooking an important ingredient in global health security. We posit that international pandemic prevention strategies, such as IHR and GHSA, can be improved by incorporating key NCD-related components. We identify 6 action areas in IHR and GHSA that are appropriate for integrating NCD-related objectives: surveillance, workforce development, laboratory systems, immunization, risk communication, and sustainable financing (3). Surveillance. Surveillance, or the collection of population health data, is a core component of disease prevention and control. Including NCD-related data in GHSA surveillance initiatives provides several advantages to health security. First, it can support the development of population risk profiles, which can inform resource mobilization and health system planning (7–9). Second, it can improve the detection of the sequelae of infectious diseases, for example, HIV-associated NCD complications (10,11). Third, by signaling responsiveness and a long-term commitment to local health needs that is not limited to emergency events, it can broaden local support of GHSA/IHR priorities (12,13). Workforce development. Workforce development refers to strengthening the skills of clinicians and other health professionals in supporting national public health priorities. Mechanisms for workforce development include initiatives such as the Field Epidemiology Training Program (14) and programs for training community health workers. The Field Epidemiology Training Program traditionally focuses on developing expertise in infectious disease epidemiology, but it can be adjusted to incorporate NCD-related curricula as well (15–17). Likewise, training programs for community health workers in countries whose populations have limited access to health care are well positioned to develop frontline workers who can bridge gaps in basic care between common NCD conditions and infectious disease prevention and control (18–20). Laboratory systems. IHR and GHSA both emphasize the importance of establishing essential laboratory capacity in participating countries (21). Besides requiring assays for detection of pathogens commonly linked to epidemic diseases such as influenza, polio, HIV, tuberculosis, malaria, and salmonella, GHSA laboratory initiatives can allow for analysis of biomarkers of key NCD conditions. This capacity may facilitate whole-patient care while increasing economies of scale in laboratory processing. Immunization. Vaccination against infectious pathogens that raise the risk of NCDs presents a unique opportunity for integrating global health security and NCD-related objectives. Vaccines for NCD risk reduction include, for example, those that protect against infection with human papillomavirus (a risk factor for cervical cancer) and hepatitis B (a risk factor for liver disease). Besides strengthening population health, vaccinations that reduce the risk of NCDs can support IHR and GHSA objectives by establishing vaccination channels among adults (22). Risk communication. Risk communication is a valuable element of pandemic control (23). Including NCD-related information in emergency risk communication plans can improve response to infectious outbreaks in populations with comorbid conditions that make them vulnerable to infection. Sustainable financing. Communicable and noncommunicable diseases increasingly depend on a shared health infrastructure (24,25). Shared infrastructure elements such as procurement channels can increase cost and operational efficiency. For example, the Pan American Health Organization Strategic Fund, a mechanism for procuring essential health supplies in the Pan American region, aggregates the supply of medications across the disease spectrum, increasing overall financial sustainability through economies of scale (26). Furthermore, NCD prevention approaches such as tobacco and alcohol taxation can be used to bolster the financial sustainability of health systems in low-income and middle-income countries (27–29). The COVID-19 pandemic has amplified the importance of NCDs to outbreak preparedness and response. It has highlighted challenges experienced by health care systems worldwide in containing a severe infectious disease outbreak intensified by concurrent chronic health conditions. The aggravating effect of NCD comorbidities that disproportionately affect socioeconomically vulnerable groups has deepened equity concerns. Responding to the compounding burden of NCDs may improve readiness for public health emergencies.
  20 in total

1.  Training and supervision of community health workers conducting population-based, noninvasive screening for CVD in LMIC: implications for scaling up.

Authors:  Shafika Abrahams-Gessel; Catalina A Denman; Carlos Mendoza Montano; Thomas A Gaziano; Naomi Levitt; Alvaro Rivera-Andrade; Diana Munguía Carrasco; Jabu Zulu; Masuma Akter Khanam; Thandi Puoane
Journal:  Glob Heart       Date:  2015-03

Review 2.  Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement.

Authors:  Trishul Siddharthan; Kaushik Ramaiya; Gerald Yonga; Gerald N Mutungi; Tracy L Rabin; Justin M List; Sandeep P Kishore; Jeremy I Schwartz
Journal:  Health Aff (Millwood)       Date:  2015-09       Impact factor: 6.301

3.  Poverty, inequality and health: the challenge of the double burden of disease in a non-profit hospital in rural Ethiopia.

Authors:  Sandro Accorsi; Nejmudin Kedir; Pasquale Farese; Shallo Dhaba; Vincenzo Racalbuto; Abera Seifu; Fabio Manenti
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-01-20       Impact factor: 2.184

Review 4.  Comparative financing analysis and political economy of noncommunicable diseases.

Authors:  Mihajlo Jakovljevic; Melitta Jakab; Ulf Gerdtham; David McDaid; Seiritsu Ogura; Elena Varavikova; Joav Merrick; Roza Adany; Albert Okunade; Thomas E Getzen
Journal:  J Med Econ       Date:  2019-04-08       Impact factor: 2.448

5.  An evaluation of the global network of field epidemiology and laboratory training programmes: a resource for improving public health capacity and increasing the number of public health professionals worldwide.

Authors:  Renee E Subramanian; Dionisio G Herrera; Paul M Kelly
Journal:  Hum Resour Health       Date:  2013-09-21

6.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.

Authors:  Andrew Clark; Mark Jit; Charlotte Warren-Gash; Bruce Guthrie; Harry H X Wang; Stewart W Mercer; Colin Sanderson; Martin McKee; Christopher Troeger; Kanyin L Ong; Francesco Checchi; Pablo Perel; Sarah Joseph; Hamish P Gibbs; Amitava Banerjee; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-06-15       Impact factor: 26.763

7.  How Thailand's greater convergence created sustainable funding for emerging health priorities caused by globalization.

Authors:  Naowarut Charoenca; Nipapun Kungskulniti; Jeremiah Mock; Stephen Hamann; Prakit Vathesatogkit
Journal:  Glob Health Action       Date:  2015-08-31       Impact factor: 2.640

8.  Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security.

Authors:  Deliana Kostova; Muhammad J Husain; David Sugerman; Yuling Hong; Mona Saraiya; Jennifer Keltz; Samira Asma
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

9.  Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016.

Authors:  Himiede W Wilson; Maame Amo-Addae; Ernest Kenu; Olayinka Stephen Ilesanmi; Donne K Ameme; Samuel O Sackey
Journal:  Biomed Res Int       Date:  2018-06-28       Impact factor: 3.411

10.  Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases.

Authors:  Rohina Joshi; Amanda G Thrift; Carter Smith; Devarsetty Praveen; Rajesh Vedanthan; Joyce Gyamfi; Jon-David Schwalm; Felix Limbani; Adolfo Rubinstein; Gary Parker; Olugbenga Ogedegbe; Jacob Plange-Rhule; Michaela A Riddell; Kavumpurathu R Thankappan; Margaret Thorogood; Jane Goudge; Karen E Yeates
Journal:  BMJ Glob Health       Date:  2018-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.